Q2 2022 Holdings
Filed 2022-08-15 | 76 holdings | $305.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $82.5M | 2,100,000 | 27.0% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $80.9M | 500,000 | 26.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $42.4M | 2,200,000 | 13.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $36.3M | 1,432,200 | 11.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $17.8M | 1,263,930 | 5.8% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $14.2M | 1,188,405 | 4.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $13.8M | 1,074,082 | 4.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.5M | 70,000 | 2.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $5.0M | 2,014,858 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.8M | 425,000 | 1.3% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $572.0K | 540,000 | 0.2% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $134.3K | 2,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $67.9K | 3,484,264 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $59.0K | 1,303,700 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $51.1K | 2,075,905 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $49.9K | 3,498,636 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $48.4K | 1,714,000 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $46.1K | 6,448,359 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $44.7K | 2,669,132 | 0.0% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $44.4K | 2,154,058 | 0.0% |
| Merus N V | COM | N5749R100 | $43.0K | 1,900,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $42.9K | 570,745 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $37.7K | 1,239,000 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $37.1K | 500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $35.3K | 1,094,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $31.1K | 6,871,642 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $30.4K | 2,202,812 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $29.6K | 3,200,000 | 0.0% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $26.4K | 1,300,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $25.6K | 507,374 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $25.0K | 2,325,000 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $23.3K | 1,847,559 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $21.4K | 1,935,133 | 0.0% |
| Day One Biopharmaceuticals(DAWN) | COM | 23954D109 | $21.3K | 1,189,943 | 0.0% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $20.6K | 2,462,358 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $20.2K | 1,466,051 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $18.3K | 600,000 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $17.0K | 2,500,000 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $16.4K | 1,210,192 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $16.3K | 1,121,327 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $15.5K | 1,224,892 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.0K | 200,000 | 0.0% |
| Nuvation Bio Inc(NUVB) | COM CL A | 67080N101 | $14.1K | 4,341,009 | 0.0% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $13.8K | 2,238,861 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $12.4K | 500,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $10.1K | 1,013,399 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $8.1K | 300,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $7.9K | 831,495 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $6.5K | 1,175,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $6.4K | 500,000 | 0.0% |